SLC39A1 and cervical squamous cell carcinoma: As shown in Figures 4C–R, the increase in the expression of SLC39A1, SLC39A 3, SLC39A 5, SLC39A 8, SLC39A 10, SLC39A 13, and SLC39A 14 was associated with poor OS, and the upregulation of SLC39A1, SLC39A 4, SLC39A 7, SLC39A 9, and SLC39A 10 was found to lead to poor RFS in the patients with CESC.